Healthcare operations

Fangzhou has launched Novo Nordisk’s once-weekly basal insulin and GLP-1 therapy in China, marking a significant step in diabetes treatment availability.

• Direct Sales Help Team
• July 20, 2026

Testing daily postpartum check-ins for first-time mothers discharged early may improve recovery and reduce risks, according to new pilot studies.

• thomey@gmail.com
• July 19, 2026

4DMT announces favorable 2-year data from its PRISM Phase 2b trial targeting wet AMD, showing promising efficacy and safety outcomes.

• Direct Sales Help Team
• July 19, 2026

A new recovery-percentile tracker for orthopedic surgery patients aims to reduce post-op calls and improve patient reassurance through personalized data.

• thomey@gmail.com
• July 17, 2026

Novartis’ Fabhalta® (iptacopan) is the first complement inhibitor approved by the FDA to slow kidney decline in primary IgA nephropathy.

• Direct Sales Help Team
• July 17, 2026

Lynk Pharmaceuticals has finalized patient enrollment for its Phase III clinical trial of Zemprocitinib targeting ankylosing spondylitis, marking a key milestone.

• Direct Sales Help Team
• July 15, 2026

Pocket Voice Lab launches a mobile app providing real-time voice feedback for gender-affirming voice training, addressing a key accessibility gap.

• thomey@gmail.com
• July 13, 2026

Alamar Biosciences will present NULISA blood-based Alzheimer’s biomarkers at over 140 sessions at AAIC 2026, highlighting advances in blood biomarker analysis.

• Direct Sales Help Team
• July 11, 2026

TaiMed Biologics has received the TFDA drug license collection notice for Trogarz, enabling commercial launch in Taiwan. Details on timing and impact are forthcoming.

• Direct Sales Help Team
• July 8, 2026

Rapid Nutrition presented its new health technology strategy on Bloomberg Television, highlighting plans to expand digital health offerings and partnerships.

• Direct Sales Help Team
• July 7, 2026